Paoletti AM - Search Results

1

Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium.

Melis GB, Paoletti AM, Bartolini R, Tosti Balducci M, Massi GB, Bruni V, Becorpi A, Ottanelli S, Fioretti P, Gambacciani M, et al. Melis GB, et al. Among authors: paoletti am. Bone Miner. 1992 Oct;19 Suppl 1:S49-56. doi: 10.1016/0169-6009(92)90866-c. Bone Miner. 1992. PMID: 1422321 Clinical Trial.

2

Lack of any estrogenic effect of ipriflavone in postmenopausal women.

Melis GB, Paoletti AM, Cagnacci A, Bufalino L, Spinetti A, Gambacciani M, Fioretti P. Melis GB, et al. Among authors: paoletti am. J Endocrinol Invest. 1992 Nov;15(10):755-61. doi: 10.1007/BF03347647. J Endocrinol Invest. 1992. PMID: 1491124 Clinical Trial.

3

Neuroendocrine and clinical effects of transdermal 17 beta-estradiol in postmenopausal women.

Cagnacci A, Melis GB, Soldani R, Paoletti AM, Gambacciani M, Spinetti A, Fioretti P. Cagnacci A, et al. Among authors: paoletti am. Maturitas. 1991 Oct;13(4):283-96. doi: 10.1016/0378-5122(91)90237-k. Maturitas. 1991. PMID: 1775082 Clinical Trial.

4

Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate.

Fioretti P, Gambacciani M, Spinetti A, Cagnacci A, Paoletti AM, Felipetto R, Melis GB. Fioretti P, et al. Among authors: paoletti am. Ann N Y Acad Sci. 1991;622:302-6. doi: 10.1111/j.1749-6632.1991.tb37875.x. Ann N Y Acad Sci. 1991. PMID: 1829595 No abstract available.

5

Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal women.

Melis GB, Cagnacci A, Gambacciani M, Paoletti AM, Caffi T, Fioretti P. Melis GB, et al. Among authors: paoletti am. Neuroendocrinology. 1988 Feb;47(2):159-63. doi: 10.1159/000124907. Neuroendocrinology. 1988. PMID: 2830551

6

Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.

Melis GB, Cagnacci A, Gambacciani M, Paoletti AM, Moggi L, Fioretti P. Melis GB, et al. Among authors: paoletti am. J Clin Endocrinol Metab. 1988 May;66(5):964-7. doi: 10.1210/jcem-66-5-964. J Clin Endocrinol Metab. 1988. PMID: 2834413

7

Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.

Melis GB, Gambacciani M, Cagnacci A, Paoletti AM, Mais V, Fioretti P. Melis GB, et al. Among authors: paoletti am. Obstet Gynecol. 1988 Nov;72(5):688-92. Obstet Gynecol. 1988. PMID: 3140150 Clinical Trial.

8

Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.

Melis GB, Mais V, Paoletti AM, Beneventi F, Gambacciani M, Fioretti P. Melis GB, et al. Among authors: paoletti am. Obstet Gynecol. 1988 Mar;71(3 Pt 1):311-4. Obstet Gynecol. 1988. PMID: 3279351 Clinical Trial.

9

Interaction between veralipride and the endogenous opioid system in the regulation of body temperature in postmenopausal women.

Cagnacci A, Melis GB, Paoletti AM, Soldani R, Fioretti P. Cagnacci A, et al. Among authors: paoletti am. Life Sci. 1988;42(5):547-53. doi: 10.1016/0024-3205(88)90096-3. Life Sci. 1988. PMID: 3339948 Clinical Trial.

10

Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: a prospective study.

Mais V, Fruzzetti F, Ajossa S, Paoletti AM, Guerriero S, Melis GB. Mais V, et al. Among authors: paoletti am. Contraception. 1993 Nov;48(5):445-52. doi: 10.1016/0010-7824(93)90134-s. Contraception. 1993. PMID: 8275694 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters